Literature DB >> 33982584

Association between cardiac high-energy phosphate metabolism and whole body metabolism in healthy female adults.

P G Wibowo1, S J Charman, N C Okwose, L Velicki, D Popovic, K G Hollingsworth, G A Macgowan, D G Jakovljevic.   

Abstract

Decline in cardiac high-energy phosphate metabolism [phosphocreatine-to-ATP (PCr/ATP) ratio] and whole body metabolism increase the risk of heart failure and metabolic diseases. The aim of the present study was to assess the relationship between PCr/ATP ratio and measures of body metabolic function. A total of 35 healthy women (56+/-14.0 years of age) underwent cardiac 31P magnetic resonance spectroscopy to assess PCr/ATP ratio - an index of cardiac high-energy phosphate metabolism. Fasting and 2-hour glucose levels were assessed using oral glucose tolerance test. Indirect calorimetry was performed to determine oxygen consumption and resting metabolic rate. There were no significant relationships between PCr/ATP ratio and resting metabolic rate (r=-0.09, p=0.62), oxygen consumption (r=-0.11, p=0.54), fasting glucose levels (r=-0.31, p=0.07), and 2-hour plasma glucose (r=-0.10, p=0.58). Adjusted analysis for covariates including age, body mass index, fat mass, and physical activity, had no significant influence on the relationship between PCr/ATP ratio and body metabolism. In conclusion, the lack of relationship between cardiac PCr/ATP ratio, glucose control and metabolic rate may suggest that overall metabolic function does not influence cardiac high-energy phosphate metabolism.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33982584      PMCID: PMC8820552          DOI: 10.33549/physiolres.934627

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  20 in total

Review 1.  Bioenergetics of the failing heart.

Authors:  Renée Ventura-Clapier; Anne Garnier; Vladimir Veksler; Frédéric Joubert
Journal:  Biochim Biophys Acta       Date:  2010-09-24

Review 2.  The failing heart--an engine out of fuel.

Authors:  Stefan Neubauer
Journal:  N Engl J Med       Date:  2007-03-15       Impact factor: 91.245

3.  New methods for calculating metabolic rate with special reference to protein metabolism.

Authors:  J B DE B WEIR
Journal:  J Physiol       Date:  1949-08       Impact factor: 5.182

Review 4.  Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies.

Authors:  Alexander Tenenbaum; Enrique Z Fisman
Journal:  Am J Cardiovasc Drugs       Date:  2004       Impact factor: 3.571

Review 5.  Energy metabolism in heart failure.

Authors:  Renée Ventura-Clapier; Anne Garnier; Vladimir Veksler
Journal:  J Physiol       Date:  2003-12-05       Impact factor: 5.182

6.  The incidence of congestive heart failure in type 2 diabetes: an update.

Authors:  Gregory A Nichols; Christina M Gullion; Carol E Koro; Sara A Ephross; Jonathan B Brown
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

7.  Insulin ameliorates exercise ventilatory efficiency and oxygen uptake in patients with heart failure-type 2 diabetes comorbidity.

Authors:  Marco Guazzi; Gabriele Tumminello; Marco Matturri; Maurizio D Guazzi
Journal:  J Am Coll Cardiol       Date:  2003-09-17       Impact factor: 24.094

Review 8.  The heart failure epidemic: a UK perspective.

Authors:  Martin R Cowie
Journal:  Echo Res Pract       Date:  2017-02-14

9.  Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.

Authors:  Michaela Scheuermann-Freestone; Per L Madsen; David Manners; Andrew M Blamire; Robin E Buckingham; Peter Styles; George K Radda; Stefan Neubauer; Kieran Clarke
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

10.  Cardiac high-energy phosphate metabolism alters with age as studied in 196 healthy males with the help of 31-phosphorus 2-dimensional chemical shift imaging.

Authors:  Regina Esterhammer; Gert Klug; Christian Wolf; Agnes Mayr; Sebastian Reinstadler; Hans-Josef Feistritzer; Bernhard Metzler; Michael F H Schocke
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.